Target intelligence / Profile preview

Synaptic vesicle glycoprotein 2C–ganglioside GT1b complex (SV2C/GT1b complex)

Target
SV2C/GT1b complex
Molecular classification
Receptor (SV2C: membrane glycoprotein receptor), Glycolipid (GT1b: ganglioside, a membrane glycolipid), Other (dual-receptor complex)
01

Overview

SV2C/GT1b complex refers to the functional receptor platform formed by **synaptic vesicle glycoprotein 2C (SV2C)** and **ganglioside GT1b** present on the surface of presynaptic cholinergic neurons. This dual-receptor complex is essential for the high-affinity binding and internalization of botulinum neurotoxin A (BoNT/A), which utilizes both carbohydrate (GT1b) and protein (SV2C) interactions for selective neuronal uptake. SV2C is a transmembrane glycoprotein with an important role in synaptic vesicle trafficking and neurotransmitter release regulation, while GT1b is a sialic acid-rich ganglioside that contributes to membrane microdomain formation and initial toxin docking. The complex is key to the pharmacological action of BoNT/A as a neuroparalytic agent and is regionally expressed in the brain, with implications for both therapeutic use and neurotoxicity in diseases such as botulism[1][2][3][4][5][6].

Other names
SV2C/GT1b receptor complexSV2C–GT1b
02

Mechanism of action

High-affinity binding of neurotoxin heavy chain (BoNT/A-HC) to both SV2C and GT1b mediates endocytosis\nEndosomal acidification triggers conformational change and translocation of toxin light chain\nThe light chain cleaves SNAP25, blocking neurotransmitter release

03

Biological functions

Neurotransmitter release regulationMediates toxin endocytosis (entry into neuron of botulinum neurotoxins)Synaptic vesicle trafficking
04

Disease associations

Infection (botulism)Neurodegenerative disease (potential roles for SV2C in Parkinson's striatum)Other (intestinal toxin passage)
05

Safety considerations

Specificity: Off-target effects if toxins interact with SV2A/SV2B or other gangliosidesNeurotoxicity: High potency effect of botulinum toxin (paralysis)Limited tissue expression: SV2C is regionally restricted, mainly striatum and some cholinergic neurons
06

Interacting drugs

Botulinum neurotoxin serotypes, especially BoNT/A

1 more in the full profile.

07

Biomarkers

SV2C protein expression for neuronal subtype targetingGT1b presence on presynaptic membranes (ganglioside biomarker)

Beyond the preview

Go deeper on Synaptic vesicle glycoprotein 2C–ganglioside GT1b complex (SV2C/GT1b complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptic vesicle glycoprotein 2C–ganglioside GT1b complex (SV2C/GT1b complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call